It isn’t often that pharmaceutical advancements break out of laboratories to be...
As Massachusetts biotech companies face dwindling investments, it appears that t...
After decades in use, heart stents finally beat placebo. It took a bold researcher.
Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a la...
How STAT's First Opinion section is trying to encourage more productive debate o...
An expert panel that advises the United Kingdom on vaccine policy has recommende...
What Amazon Prime's new One Medical offering reveals about the future of health ...
A hospital affiliated with Harvard is testing whether hallucinogenic mushrooms c...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Novo Nordisk announced a plan to spend a whopping $6 billion to expand its manuf...
Two days after similar decisions in the U.S. and U.K., regulators in Europe on F...
Doctors are staring down a cut to their Medicare pay next year, and while the ne...
State and local governments across the country are sidelining science.
Lack of access to a nearby pharmacy can have major health consequences by impedi...
Pre-med requirements have very little to do with what medical students and docto...
A pared-back field of five GOP presidential candidates sparred Wednesday night, ...
